Welcome to Roslindale Pediatrics

We are listening!

Posted by on June 26, 2017 in News | Comments Off on We are listening!

A big thanks to those of you that have completed our survey. We are striving to make your experience here excellent.

As a result of feedback here are some of the improvements that are happening.

  • Our child safety locks for the rooms have arrived and will be installed soon
  • We will be reinstituting the books in the rooms soon- in the meantime we do have children’s books in the waiting rooms
  • Thanks for your patience as we continue to add more decorations to the patient rooms

Keep your eyes out for more improvements in the upcoming months! Keep the suggestions coming.

RPApatientfeedback@gmail.com

https://www.surveymonkey.com/r/3JKPV3H

Tick Guidelines

Posted by on June 2, 2017 in News | Comments Off on Tick Guidelines

It is a great time of year to enjoy the outdoors, but make sure you and your kids are safe.  The AAP has some great guidelines about ticks.  Click on the link below for information.  If you have anymore questions, please give us a call.

tick guidelines

 

EPIPEN RECALL

Posted by on April 3, 2017 in News | Comments Off on EPIPEN RECALL

The U.S. Food and Drug Administration is alerting consumers to Meridian Medical Technologies’ voluntary recall
of 13 lots of Mylan’s EpiPen and EpiPen Jr (epinephrine injection) Auto-Injector products used for emergency treatment of severe allergic reactions. This recall is due to the potential that these devices may contain a defective part that may result in the devices’ failure to activate. The recalled product was manufactured by Meridian Medical Technologies and distributed by Mylan Specialty.
While the number of reported failures is small, EpiPen products that potentially contain a defective part are being recalled because of the potential for life-threatening risk if a severe allergic reaction goes untreated. Consumers should keep and use their current EpiPens if needed until they get a replacement. Consumers should contact Mylan at 800-796-9526 or customer.service@mylan.com with any questions.
As stated on the product label, consumers should always seek emergency medical help right away after using their EpiPens, particularly if the device did not activate.
At this time, the 13 lots identified – distributed between Dec. 17, 2015, and July 1, 2016 – are the only EpiPen lots impacted by the U.S. recall. Consumers who have EpiPens from lots that are not included in this recall, do not need to replace their EpiPen prior to its expiration date.
Product/Dosage NDC Number Lot Number Expiration Date
EpiPen Jr Auto-Injector, 0.15 mg 49502-501-02 5GN767 April 2017
EpiPen Jr Auto-Injector, 0.15 mg 49502-501-02 5GN773 April 2017
EpiPen Auto-Injector, 0.3 mg 49502-500-02 5GM631 April 2017
EpiPen Auto-Injector, 0.3 mg 49502-500-02 5GM640 April 2017
EpiPen Jr Auto-Injector, 0.15 mg 49502-501-02 6GN215 September 2017
EpiPen Auto-Injector, 0.3 mg 49502-500-02 6GM082 September 2017
EpiPen Auto-Injector, 0.3 mg 49502-500-02 6GM072 September 2017
EpiPen Auto-Injector, 0.3 mg 49502-500-02 6GM081 September 2017
EpiPen Auto-Injector, 0.3 mg 49502-500-02 6GM088 October 2017
EpiPen Auto-Injector, 0.3 mg 49502-500-02 6GM199 October 2017
EpiPen Auto-Injector, 0.3 mg 49502-500-02 6GM091 October 2017
EpiPen Auto-Injector, 0.3 mg 49502-500-02 6GM198 October 2017
EpiPen Auto-Injector, 0.3 mg 49502-500-02 6GM087 October 2017